Dr. James Girard Glauber - NPI #1609889831

Hematologist & Oncologist located in St Louis, MO

Missouri St Louis Hematology & Oncology Dr. James Girard Glauber Information


Dr. James Girard Glauber is a male Hematologist & Oncologist (taxonomy code 207RH0003X) located in St Louis, Missouri. Dr. James Girard Glauber's NPI Number is #1609889831 and has been listed in the NPI registry for 12 years. Dr. James Girard Glauber's practice location is listed as: 6400 Clayton Rd Ste 302 St Louis, MO 63117-1850 and can be reached via phone at (314) 645-3432.

Hematology & Oncology Taxonomy

The taxonomy code for Dr. James Girard Glauber's main specialty, Hematology & Oncology, is 207RH0003X. An internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered.



Be the first to rate Dr. Glauber

Thanks for sharing your opinion!

‡ Descriptions, provider messages, and reviews are user submitted. While we make our best effort to verify the accuracy of information submissions, DocBios cannot guarantee that the information is accurate and/or up to date. Please verify any and/or all information with the provider. DocBios is not an advice or referral service and does not guarantee, approve, or endorse any particular healthcare provider.

Health Care Provider Information
 NPI # 1609889831
 Phone (314) 645-3432
 Fax (314) 645-3191
6400 Clayton Rd
Ste 302
St Louis, MO 63117-1850
 Gender M
 Website Not provided
  • Hematology & Oncology (MO)
Business Information
  • Sole Proprietor? No
  • Is Sub-Organization? Not Available
  • Parent Org Name: Not Available
 Updated 1/30/2013
 Added 8/15/2006
 Viewed on 4/24/2018
Health Care Providers Nearby

Thanks! Your edit was sucessfully submitted. Changes will be displayed after DocBios.com editors have reviewed your submission.